Profile
Mr. Gerhard Musshafen is a Director at Neurotune AG and Chairman at Prionics AG.
Mr. Musshafen was previously employed as Founder by HealthCare Partners LLC, a Member-Executive Board by Immuno AG, and a Principal by Boehringer Mannheim GmbH.
He received his undergraduate degree from Universität Stuttgart.
Former positions of Gerhard Musshafen
Companies | Position | End |
---|---|---|
HealthCare Partners LLC
HealthCare Partners LLC Medical DistributorsDistribution Services HealthCare Partners LLC manages the administrative systems of HealthCare Partners Medical Group. The firm also provides support services to its independent physician association (IPA) network. It also offers strategic planning, implementation, and development of integrated delivery systems, and offers expertise in IPA and medical group formation. The company was founded in 1992 and is headquartered in El Segundo, CA. | Founder | 01/01/2005 |
Immuno AG | Corporate Officer/Principal | 01/01/1995 |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Corporate Officer/Principal | 01/01/1994 |
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Chairman | - |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Corporate Officer/Principal | - |
Training of Gerhard Musshafen
Universität Stuttgart | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Health Technology |
HealthCare Partners LLC
HealthCare Partners LLC Medical DistributorsDistribution Services HealthCare Partners LLC manages the administrative systems of HealthCare Partners Medical Group. The firm also provides support services to its independent physician association (IPA) network. It also offers strategic planning, implementation, and development of integrated delivery systems, and offers expertise in IPA and medical group formation. The company was founded in 1992 and is headquartered in El Segundo, CA. | Distribution Services |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
Immuno AG |
- Stock Market
- Insiders
- Gerhard Musshafen